A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Discussion Forum: Valeo Pharma Inc.
List Message View
Thread Message View
New Message
Author / Date /
Topic Title
Rating
Re
Last Post
AGORACOM-AC - Mar 10, 2023 08:35AM
Icon agoracom Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing

1
AlexHopkins
Apr 02, 2023 10:38PM
AGORACOM-AC - Mar 17, 2023 11:40AM
Icon agoracom Valeo Pharma sees record quarterly revenue with a triple-digit increase over 1Q 2022

1
monkeymart
Mar 26, 2023 10:30PM
AGORACOM-AC - Mar 15, 2023 05:00PM
Icon agoracom VALEO PHARMA REPORTS RECORD QUARTERLY REVENUES FOR THE FIRST QUARTER 2023

0
AGORACOM-AC
Mar 15, 2023 05:00PM
AGORACOM-AC - Mar 09, 2023 07:00AM
Icon agoracom VALEO PHARMA TO HOST FIRST QUARTER 2023 RESULTS CONFERENCE CALL / WEBCAST

0
AGORACOM-AC
Mar 09, 2023 07:00AM
AGORACOM-AC - Mar 07, 2023 08:35AM
Icon agoracom Life Sciences Virtual Investor Forum Agenda Announced for March 9th

0
AGORACOM-AC
Mar 07, 2023 08:35AM
AGORACOM-AC - Mar 06, 2023 08:35AM
Icon agoracom Valeo Pharma to Webcast Live at Virtual Investor Conference March 9th

0
AGORACOM-AC
Mar 06, 2023 08:35AM
AGORACOM-AC - Feb 07, 2023 07:00AM
Icon agoracom VALEO PHARMA OBTAINS PUBLIC REIMBURSEMENT FOR ONSTRYV® IN QUEBEC

1
hendye
Feb 23, 2023 09:17PM
AGORACOM-AC - Jan 30, 2023 05:03PM
Icon agoracom VALEO PHARMA REPORTS RECORD QUARTERLY AND ANNUAL REVENUES FOR THE FOURTH QUARTER AND THE FISCAL YEAR 2022

0
AGORACOM-AC
Jan 30, 2023 05:03PM
AGORACOM-AC - Jan 26, 2023 07:00AM
Icon agoracom VALEO PHARMA ANNOUNCES FILING OF A NEW DRUG SUBMISSION-COVID 19 WITH HEALTH CANADA FOR SABIZABULIN FOR THE TREATMENT OF HOSPITALIZED COVID-19 PATIENTS

0
AGORACOM-AC
Jan 26, 2023 07:00AM
AGORACOM-AC - Jan 25, 2023 09:38AM
Icon agoracom VALEO PHARMA TO HOST FOURTH QUARTER AND YEAR-END 2022 RESULTS CONFERENCE CALL / WEBCAST

0
AGORACOM-AC
Jan 25, 2023 09:38AM
AGORACOM-AC - Nov 21, 2022 05:13PM
Icon agoracom VALEO PHARMA ANNOUNCES SENIOR MANAGEMENT CHANGE

0
AGORACOM-AC
Nov 21, 2022 05:13PM
AGORACOM - Sep 23, 2021 03:35PM
Icon agoracom INTERVIEW ALERT: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB)

1
amityusa
Nov 16, 2022 09:12PM
AGORACOM-AC - Nov 15, 2022 07:00AM
Icon agoracom VALEO PHARMA RAISES Q4 AND FULL YEAR 2022 REVENUE GUIDANCE

0
AGORACOM-AC
Nov 15, 2022 07:00AM
AGORACOM-KE - Mar 10, 2022 11:53AM
Icon agoracom AGORACOM Small Cap 60: 2022 Is Shaping Up To Be Transformational Year For Valeo Pharma (VPH: CSE)

3
maryer
Oct 31, 2022 04:16AM
AGORACOM-KE - Sep 14, 2022 07:00AM
Icon agoracom Valeo Pharma Enters Into Canadian Commercial Services Agreement With Veru For Sabizabulin In Hospitalized Adult Patients With Covid-19 At High Risk...

0
AGORACOM-KE
Sep 14, 2022 07:00AM
AGORACOM-KE - Sep 13, 2022 05:14PM
Icon agoracom VALEO PHARMA REPORTS RECORD THIRD QUARTER 2022 RESULTS AND HIGHLIGHTS

0
AGORACOM-KE
Sep 13, 2022 05:14PM
AGORACOM-KE - Sep 09, 2022 07:00AM
Icon agoracom VALEO PHARMA TO HOST THIRD QUARTER 2022 RESULTS CONFERENCE CALL / WEBCAST

0
AGORACOM-KE
Sep 09, 2022 07:00AM
AGORACOM-KE - Aug 30, 2022 07:00AM
Icon agoracom VALEO PHARMA ADDS PHARMACEUTICAL INDUSTRY VETERAN KYLE STEIGER TO LEADERSHIP TEAM

0
AGORACOM-KE
Aug 30, 2022 07:00AM
AGORACOM-KE - Aug 02, 2022 08:30AM
Icon agoracom VALEO PHARMA CLOSES US$40 MILLION NON-DILUTIVE FINANCING FROM SAGARD HEALTHCARE PARTNERS

0
AGORACOM-KE
Aug 02, 2022 08:30AM
AGORACOM-KE - Aug 02, 2022 07:45AM
Icon agoracom VALEO PHARMA ENTERS INTO LICENSE AGREEMENT WITH KALÉO FOR THE CANADIAN RIGHTS TO ALLERJECT®

0
AGORACOM-KE
Aug 02, 2022 07:45AM
New Message